MPA (Mycophenolic Acid)

The "MPA (Mycophenolic Acid) Therapeutic Drug" test is performed to measure the levels of mycophenolic acid in the blood of patients who are undergoing immunosuppressive therapy, typically after organ transplantation. Mycophenolic acid is an immunosuppressive drug commonly used to prevent organ rejection in transplant recipients. This test helps monitor the concentration of mycophenolic acid in the patient's blood to ensure that the drug is within the therapeutic range. Maintaining the appropriate levels of mycophenolic acid is crucial for effective immunosuppression while minimizing the risk of adverse effects. By monitoring the drug levels, healthcare providers can adjust the dosage to achieve the optimal balance between preventing organ rejection and avoiding drug-related complications. Regular monitoring of mycophenolic acid levels is essential to ensure the success of immunosuppressive therapy and the long-term health of transplant recipients.